Autologous Tumor-Infiltrating Lymphocyte Infusion plus Anti-Programmed Cell Death Protein 1 Therapy to Cure Advanced Hepatocellular Carcinoma following Palliative Hepatectomy
Autologous TIL infusion combined with anti-PD-1 therapy is a safe and feasible strategy for patients with aHCC. Palliative hepatectomy with maximal tumor burden reduction may significantly improve its efficacy and even results in cure for aHCC patients.
Authors
- Tian Xia (ORCID: https://orcid.org/0000-0002-0601-0467)
- Zunyi Zhang
- Tong Yuan (ORCID: https://orcid.org/0000-0003-3211-1322)
- Lijun Chen (ORCID: https://orcid.org/0000-0001-9374-6466)
- Xiaoping Chen (ORCID: https://orcid.org/0000-0003-3048-2699)
- Huang Zhiyong (ORCID: https://orcid.org/0000-0002-5208-3149)
- Changli Wang (ORCID: https://orcid.org/0000-0003-1075-5071)
- Binyong Liang (ORCID: https://orcid.org/0000-0001-9347-4958)
- Erlei Zhang (ORCID: https://orcid.org/0000-0002-7251-0275)
- Ming-Wei Wang
Institutions
- Institute of Deep-Sea Science and Engineering (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Liver Cancer
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1159/000544163
- Citations
- 1
- Primary Topic
- Cancer Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.23
Funders
- National Natural Science Foundation of China
- Tongji University